Associated Papers
The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants.
Wang S et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University, 2023
Select a paper to view details